ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

COO vs LLY // RETURN ON INVESTED CAPITAL (ROIC)

The Cooper Companies Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: COO 3 — LLY 12
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LLY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COO VS. LLY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC COO LLY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 65.50% 83.64% -18.14 LLY /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE 5.30% 32.36% -27.06 LLY /roic <GO>
EV/EBITDA & P/E Valuation 13.3x 36.4x -23.12 COO /valuation <GO>
Free Cash Flow Yield 3.78% 2.30% +1.48 COO /fcf-yield <GO>
Operating Margin 16.70% 40.21% -23.51 LLY /operating-margins <GO>
Net Profit Margin 9.20% 31.90% -22.70 LLY /net-margins <GO>
Revenue Growth (YoY) 5.10% 45.51% -40.41 LLY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.49% -0.49 LLY /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.13 9.29 -6.16 LLY /balance-sheet <GO>
Piotroski F-Score Quality 8/9 9/9 -1.00 LLY /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.90% 6.77% +0.13 LLY /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.5 77.9 -25.36 LLY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.01 0.51 +0.50 COO /macro-sensitivity <GO>
Forward P/E Multiple 28.5x 26.3x +2.25 LLY /forward-pe <GO>
Enterprise Scale & Market Cap $11.47B $1.33T -$1.32T LLY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR COO REV LLY REV COO GROSS % LLY GROSS % COO FCF LLY FCF
FY 2025 $4.09B $65.18B 65.5% 83.0% $433.7M $16.81B
FY 2024 $3.90B $45.04B 66.6% 81.3% $288.1M $8.82B
FY 2023 $3.59B $34.12B 44.0% 79.3% $445.8M $4.24B
FY 2022 — $28.54B — 76.8% — $7.59B
FY 2021 — $28.32B — 74.2% — $7.37B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COO // BETA 1.01
LLY // BETA 0.51